Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totaling 37,633 shares, an increase of 596.8% from the May 31st total of 5,401 shares. Based on an average daily volume of 8,253 shares, the days-to-cover ratio is currently 4.6 days. Approximately 3.8% of the shares of the company are short sold.
Global X HealthTech ETF Trading Up 1.0%
HEAL stock traded up $0.28 during trading on Friday, hitting $27.29. The company had a trading volume of 1,368 shares, compared to its average volume of 11,378. The business has a 50 day moving average of $25.40 and a 200 day moving average of $26.74. The firm has a market capitalization of $27.29 million, a price-to-earnings ratio of 42.80 and a beta of 1.12. Global X HealthTech ETF has a fifty-two week low of $23.00 and a fifty-two week high of $33.59.
Institutional Trading of Global X HealthTech ETF
A number of institutional investors have recently made changes to their positions in the stock. Glenmede Investment Management LP acquired a new stake in shares of Global X HealthTech ETF in the 3rd quarter worth approximately $31,000. Banque Cantonale Vaudoise bought a new stake in Global X HealthTech ETF during the third quarter worth approximately $37,000. EverSource Wealth Advisors LLC raised its holdings in Global X HealthTech ETF by 26,522.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock worth $70,000 after purchasing an additional 2,387 shares in the last quarter. Royal Bank of Canada lifted its position in Global X HealthTech ETF by 39.4% in the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after purchasing an additional 736 shares during the period. Finally, Farther Finance Advisors LLC acquired a new stake in Global X HealthTech ETF in the fourth quarter worth approximately $111,000.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Articles
- Five stocks we like better than Global X HealthTech ETF
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
- Data Center Delays Create Opportunity in These 3 Stocks
- Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally Here
- Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
